Position in IMUX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,195,000
+$26,759,044 QoQ
Shares Held
2,450,000
+3822.6% QoQ
Ownership
18.0%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#9
of 78 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $329,314,446 across 63 Biotechnology names. IMUX ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | IMUX |
Immunic, Inc.
This page
|
2,450,000 | $27,195,000 | |
| 4 | ANAB |
Anaptysbio, Inc
|
625,000 | $23,108,312 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 6 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 |
All Filings in IMUX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,195,000 | 2,450,000 | Shares | Defined | 2026-05-15 | |
| 2025-08-02 | $9,911,303 | 10,634,446 | Shares | Sole | 2025-08-08 | |
| 2025-06-30 | $435,956 | 62,458 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,810,000 | 900,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,000,000 | 700,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,296,741 | 684,651 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,762,241 | 699,301 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,230,773 | 699,301 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||